[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341685-105":59,"doc-detail-341685-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","guideline-for-designing-microbiome-studies-in-neoplastic-diseases-suggested-metadata-set","Guideline for designing microbiome studies in neoplastic diseases - suggested metadata set","","Oncobiosis is a central factor in cancer development and in modulating treatment effectiveness. The review synthesizes how the oncobiome can promote tumor progression and identifies emerging therapeutic opportunities, while detailing major obstacles in sampling and accurately characterizing oncobiome communities. It emphasizes the need to standardize microbial analysis methods and to report microbiome data consistently. A suggested metadata set is proposed for oncological microbiome datasets to keep studies comparable and interpretable.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/guideline-for-designing-microbiome-studies-in-neoplastic-diseases-suggested-metadata-set/341685/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/guideline-for-designing-microbiome-studies-in-neoplastic-diseases-suggested-metadata-set/341685.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is oncobiosis and how is it linked to cancer?","Question",{"text":112,"@type":113},"Oncobiosis describes dysbiosis of microbiome compartments in the presence of neoplasia. It is associated with cancer progression and includes altered communities across multiple niches, depending on cancer type.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can the oncobiome support tumor progression and metastasis?",{"text":117,"@type":113},"The oncobiome may act through direct interactions with cancer cells, modulation of the immune system, and alterations of the local tumor microenvironment. It may also influence how anticancer therapy performs.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does the review stress standardization and consistent reporting?",{"text":121,"@type":113},"Sampling and characterization of the oncobiome are challenging and can introduce limitations. Standardized microbial analysis techniques and consistent microbiome reporting help ensure findings remain comparable and decipherable.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341685,1791097367,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","GeroScience (2024) 46:4037–4057  \n[https://doi.org/10.1007/s11357-024-01255-4](https://doi.org/10.1007/s11357-024-01255-4)  \nGuideline for designing microbiome studies in neoplastic diseases  \nEdit Mikó · Adrienn Sipos · Emese Tóth ·  \nAndrea Lehoczki · Monika Fekete · Éva Sebő ·  \nGábor Kardos · Péter Bai  \nReceived: 20 May 2024 / Accepted: 12 June 2024 / Published online: 26 June 2024 © The Author(s) 2024  \nAbstract Oncobiosis has emerged as a key contributor to the development, and modulator of the treatment efficacy of cancer. Hereby, we review the modalities through which the oncobiome can support the progression of tumors, and the emerging therapeutic opportunities they present. The review highlights the inherent challenges and limitations faced in sampling and accurately characterizing oncobiome. Additionally, the review underscores the critical  \nneed for the standardization of microbial analysis techniques and the consistent reporting of microbiome data. We provide a suggested metadata set that should accompany microbiome datasets from oncological settings so that studies remain comparable and decipherable.  \nKeywords Cancer · Microbiome · Guideline · Stage · Grade · Molecular subtype · Aging · Age  \nEdit Mikó, Adrienn Sipos, and Emese Tóth have equal contributions to this study.  \nE. Mikó · A. Sipos · E. Tóth · P. Bai (*)  \nDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem Tér 1., 4032 Debrecen, Hungary  \n[e-mail: baip@med.unideb.hu](e-mail: baip@med.unideb.hu)  \nE. Tóth · P. Bai  \nHUN-REN-DE Cell Biology and Signaling Research Group, 4032 Debrecen, Hungary  \nA. Lehoczki  \nDepartment of Hematology and Stem Cell Transplantation, South Pest Central Hospital-National Institute for Hematology and Infectious Diseases, Budapest, Hungary  \nA. Lehoczki  \nDoctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary  \nA. Lehoczki · M. Fekete  \nDepartment of Public Health, Semmelweis University, Budapest, Hungary  \nÉ . Sebő  \nBreast Center, Kenézy Gyula Hospital, University of Debrecen, 4032 Debrecen, Hungary  \nG. Kardos  \nDepartment of Metagenomics, University of Debrecen, 4032 Debrecen, Hungary  \nG. Kardos  \nFaculty of Health Sciences, One Health Institute, University of Debrecen, 4032 Debrecen, Hungary  \nP. Bai  \nMTA-DE Lendület Laboratory of Cellular Metabolism, 4032 Debrecen, Hungary  \nP. Bai  \nResearch Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary  \nIntroduction  \nCancer remains one of the leading causes of morbidity and mortality worldwide, with breast cancer accounting for a significant proportion of these cases [1, 2] . Amidst the myriad of factors contributing to cancer progression, the role of microorganisms, particularly bacteria, has emerged as a critical area of research [3–10] . Oncobiome refers to a microbiome with altered composition in cancer patients, which is implicated in supporting progression, and metastasis of various cancers, including breast cancer [11–13] . The oncobiome can influence cancer through direct interactions with cancer cells, modulation of the immune system, or alterationsin the local tumor microenvironment [13] . The oncobiome is thought to interact with anticancer therapy as well, influencing efficacy and outcome [14] . This review aims to dissect the current understanding oncobiosis, highlighting key findings, challenges, and future directions in this evolving field and to provide a comprehensive reporting and sampling guideline for oncobiome studies.  \nncobiome: an overview  \nThe intricate relationship between the human microbiome and cancer has garnered significant attention, leading to the identification of a phenomenon known as oncobiosis [15] . Oncobiosis refers to the dysbiosis of microbiome compartments in the presence of neoplasia, which is often associated with cancer progression, representing a shift away from the normal microbial balance [15] . This alteration in th","cbCaitmEVjhLROOO","https://ap.wps.com/l/cbCaitmEVjhLROOO","pdf",1071155,21,"English","# Abstract\n# Introduction\n## Oncobiome: an overview","[{\"question\":\"What is oncobiosis and how is it linked to cancer?\",\"answer\":\"Oncobiosis describes dysbiosis of microbiome compartments in the presence of neoplasia. It is associated with cancer progression and includes altered communities across multiple niches, depending on cancer type.\"},{\"question\":\"How can the oncobiome support tumor progression and metastasis?\",\"answer\":\"The oncobiome may act through direct interactions with cancer cells, modulation of the immune system, and alterations of the local tumor microenvironment. It may also influence how anticancer therapy performs.\"},{\"question\":\"Why does the review stress standardization and consistent reporting?\",\"answer\":\"Sampling and characterization of the oncobiome are challenging and can introduce limitations. Standardized microbial analysis techniques and consistent microbiome reporting help ensure findings remain comparable and decipherable.\"}]","Guideline for designing microbiome studies in neoplastic diseases - suggested metadata set | PDF",1790043185,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8a44df6a2655e619d363daa8c519dae.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d5adb1c4d261b17095e4c8ba6cf8eda.webp",982,1322,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37b2744da7cc7b6eeaf117f19b7e2685.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99fa7735f6a73d343407047128ab2eaf.webp",980,1319]